auto
Find a product
Back to results

WesternBright Sirius HRP Substrate Advansta #K-12043

WesternBright Sirius HRP Substrate

  • Company: Advansta
  • Product code: K-12043
  • Review rating:4.00 (1 review)

Product Details

1DB_ID: 1DB-001-0001888862
Company: Advansta
Company product code: K-12043
Product name: WesternBright Sirius HRP Substrate
Product type: Kit
Multiple sizes available: 2x20 ml (for 200 cm2 of membrane) / ; 2x100 ml (for 1000 cm2 of membrane) / ; 2x200ml (for 2000 cm2 of membrane) /
Target: HRP
Product function: substrate
Conjugation: HRP
Description: WesternBright Sirius is the most sensitive chemiluminescent substrate available for Western blotting. Its extremely strong signal allows detection of bands unseen with other substrates.

Features
  • The most sensitive of Advansta's HRP substrates
  • Quantitative signal
  • Also emits chemifluorescence for detection using fluorescence imagers

Reviews (1)

4 - Excellent (Publishable / Ideal reagent)
Application: WB
Sample: several cell line such as A172, U251, U87,
Buffer: attached
Dilution: as in protocols
See all reviews

1DegreeBio goes to great lengths to ensure the accuracy of the product information listed on the site, but we still encourage you to check with vendors to confirm product details before purchasing.

About Advansta

Founded in 2005 and headquartered in Menlo Park, California, Advansta is an evolving international company, which develops, manufactures and markets a wide range of specialized bio-research reagents that simplify, accelerate and improve life sciences research. Our mission is to be the leading developer and supplier of products to support research in understanding the dynamics of biological events.

Advansta's focus is developing solutions to precisely characterize molecular events that occur in cells. Our products are based on the following principles:

  • Quantitation of cellular events that occur in parallel
  • Real time, direct measurement of intracellular molecular dynamics
  • Functional analysis of disease states and drug candidates